Drug recall · February 22, 2023
CEFEPIME recall
Why: Lack of sterility assurance
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
CEFEPIME, (a) 2GM IN NS 100ML (b)8GM IN NS 400ML (c) 12GM IN NS 600ML, used with a Curlin or Home pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320
- Lots / codes
Beyond Use Date December 24-31, 2022
- Quantity
- 71 bags total
- Company
- Sentara Infusion Services, Chesapeake, VA
- Distribution
- Dispensed to Patients Nationwide.
- Initiated
- December 27, 2022 · Voluntary: Firm initiated
- Classified
- February 15, 2023
- Reported
- February 22, 2023
- Ended
- February 20, 2026
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cefepime
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.